×
Back to Agenda
Applied Innovation for Patients: Implementing AI, Cloud, and Data in Regulatory Science
Session Chair(s)
Rebecca Nebel, PHD
Deputy Vice President, Science and Regulatory Advocacy
PhRMA, United States
This session explores strategies to implement AI, cloud, and different data sources across the drug lifecycle and in regulatory activities to deliver patient benefits. Experts will discuss pilots, policies, and partnerships that can enable faster access to safe and effective medicines.
Learning Objective : Explain how AI, cloud, and data can be utilized in regulatory processes to accelerate patient access to therapies; Assess implementation strategies that balance innovation with patient safety and trust; Identify collaborative models that embed patient-centric principles into digital regulatory ecosystems.
Speaker(s)
Panelist
Kimberly Ann Beer
National Health Council, United States
Senior Vice President, Policy & External Affairs
Panelist
Representative Invited
FDA, United States
Panelist
Andrew Robertson, JD, PHD
Takeda, United States
Vice President, Head of Global Regulatory Policy and Innovation
Panelist
Jonathan Walsh, PHD
Unlearn.AI, United States
Chief Scientific Officer
Have an account?